日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial

针对健康成年人的尼帕病毒结构型mRNA疫苗:一项I期临床试验

Ploquin, Aurélie; Mason, Rosemarie D; Holman, LaSonji A; Happe, Myra; Widge, Alicia T; Novik, Laura; Ortega-Villa, Ana M; Yamshchikov, Galina V; Gordon, Ingelise J; Ola, Abidemi; Arthur, Anita; Costner, Pamela J M; Mendoza, Floreliz; Saunders, Jamie; Wang, Xioalin; Whalen, William R; Utoh, Joanna; Cunningham, Jennifer; Loftus, Lorin N; Heimann, Ashley; Korzeniwsky, Katia; Andrew, Shayne F; Lamb, Evan; Shyam Sunder, Shruthi; Thompson, Amelia; McDonald, Mary; Foulds, Kathryn E; Sullivan, Nancy J; Bahorich, Jessica; Coates, Emily E; Loomis, Rebecca J; Graham, Barney S; Bok, Karin; Himansu, Sunny; Leav, Brett; Dempsey, Walla; Beigel, John H; Roederer, Mario; Dropulic, Lesia K

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

在一项 I 期临床试验中,接种 mRNA 编码的膜锚定 HIV 包膜三聚体疫苗可诱导产生 2 级中和抗体。

Parks, K Rachael; Moodie, Zoe; Allen, Mary A; Yen, Catherine; Furch, Briana D; MacPhee, Kellie J; Ozorowski, Gabriel; Heptinstall, Jack; Hahn, William O; Zheng, Zihan; Lu, Huiyin; Grant, Shannon; Domin, Elize; Duff, Michael O; Seese, Aaron; Marini-Macouzet, Constanza; Ballweber-Fleming, Lamar; Lee, Wen-Hsin; Cottrell, Christopher A; Liguori, Alessia; Georgeson, Erik; Alavi, Nushin; Kubitz, Michael; Phelps, Nicole; Seaton, Kelly E; Cohen, Kristen W; Anderson, Maija A; Mondal, Kajari; Laufer, Dagna S; Kublin, James G; Ward, Andrew B; Hyrien, Ollivier; De Rosa, Stephen C; Himansu, Sunny; Leav, Brett; Reuter, Caroline; Tomaras, Georgia D; Montefiori, David; Walsh, Stephen R; Frank, Ian; Sobieszczyk, Magdalena E; Goepfert, Paul A; Stephenson, Kathryn E; Baden, Lindsey R; Van Tieu, Hong; Keefer, Michael C; Clark, Jesse; Riddler, Sharon A; Schief, William R; McElrath, M Juliana

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials

未接种疫苗者首次感染时鼻咽部SARS-CoV-2病毒载量:4项随机试验的二次交叉方案分析

Fisher, Leigh H; Kee, Jia Jin; Liu, Albert; Espinosa, Claudia M; Randhawa, April K; Ludwig, James; Magaret, Craig A; Robinson, Samuel T; Gilbert, Peter B; Hyrien, Ollivier; Kublin, James G; Rouphael, Nadine; Falsey, Ann R; Sobieszczyk, Magdalena E; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Kotloff, Karen L; Gay, Cynthia L; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Huang, Yunda; Goepfert, Paul A; Walsh, Stephen R; Baden, Lindsey R; Janes, Holly

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

来自4项随机对照试验的新冠疫苗在免疫系统较弱的参与者中的有效性

Sherman, Amy C; Tuan, Jessica; Cantos, Valeria D; Adeyiga, Oladunni; Mahoney, Scott; Ortega-Villa, Ana M; Tillman, Amy; Whitaker, Jennifer; Woodward Davis, Amanda S; Leav, Brett; Hirsch, Ian; Sadoff, Jerald; Dunkle, Lisa M; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Goepfert, Paul A; Kotloff, Karen; Rouphael, Nadine; Falsey, Ann R; El Sahly, Hana M; Sobieszczyk, Magdalena E; Huang, Yunda; Neuzil, Kathleen M; Corey, Lawrence; Grinsztejn, Beatriz; Gray, Glenda; Nason, Martha; Baden, Lindsey R; Gay, Cynthia L

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

一项随机试验表明,在成人中同时接种季节性四价流感疫苗和 COVID-19 mRNA-1273 加强疫苗,不会产生免疫干扰或安全隐患:

Naficy, Abdi; Kuxhausen, Adrienne; Seifert, Harry; Hastie, Andrew; Leav, Brett; Miller, Jacqueline; Anteyi, Kate; Mwakingwe-Omari, Agnes

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study

在南非医护人员中,使用Ad26.COV2.S初次免疫后,异源mRNA-1273加强免疫的安全性、有效性和免疫原性:单臂、开放标签、3期SHERPA研究

Garrett, Nigel; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Takalani, Azwidhwi; Woeber, Kubashni; Bodenstein, Annie; Jonas, Phumeza; Engelbrecht, Imke; Jassat, Waasila; Moultrie, Harry; Bradshaw, Debbie; Seocharan, Ishen; Odhiambo, Jackline; Khuto, Kentse; Richardson, Simone I; Omondi, Millicent A; Nesamari, Rofhiwa; Keeton, Roanne S; Riou, Catherine; Moyo-Gwete, Thandeka; Innes, Craig; Zwane, Zwelethu; Mngadi, Kathy; Brumskine, William; Naicker, Nivashnee; Potloane, Disebo; Badal-Faesen, Sharlaa; Innes, Steve; Barnabas, Shaun; Lombaard, Johan; Gill, Katherine; Nchabeleng, Maphoshane; Snyman, Elizma; Petrick, Friedrich; Spooner, Elizabeth; Naidoo, Logashvari; Kalonji, Dishiki; Naicker, Vimla; Singh, Nishanta; Maboa, Rebone; Mda, Pamela; Malan, Daniel; Nana, Anusha; Malahleha, Mookho; Kotze, Philip; Allagappen, Jon J; Diacon, Andreas H; Kruger, Gertruida M; Patel, Faeezah; Moore, Penny L; Burgers, Wendy A; Anteyi, Kate; Leav, Brett; Bekker, Linda-Gail; Gray, Glenda E; Goga, Ameena

Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients

癌症患者接种第三剂mRNA-1273疫苗的安全性和免疫原性

Giuliano, Anna; Kuter, Barbara; Pilon-Thomas, Shari; Whiting, Junmin; Mo, Qianxing; Leav, Brett; Sirak, Bradley; Cubitt, Christopher; Dukes, Christopher; Isaacs-Soriano, Kimberly; Kennedy, Kayoko; Ball, Somedeb; Dong, Ning; Jain, Akriti; Hwu, Patrick; Lancet, Jeffrey

Risk of COVID-19 after natural infection or vaccination

自然感染或接种疫苗后感染新冠病毒的风险

Rick, Anne-Marie; Laurens, Matthew B; Huang, Ying; Yu, Chenchen; Martin, Thomas C S; Rodriguez, Carina A; Rostad, Christina A; Maboa, Rebone M; Baden, Lindsey R; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Gay, Cynthia L; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Huang, Yunda; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Goepfert, Paul A; Walsh, Stephen R; Follmann, Dean; Kotloff, Karen L

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials

成人 COVID-19、重症 COVID-19 和 SARS-CoV-2 感染的临床和人口统计学因素:4 项随机临床试验的二次交叉方案分析

Theodore, Deborah A; Branche, Angela R; Zhang, Lily; Graciaa, Daniel S; Choudhary, Madhu; Hatlen, Timothy J; Osman, Raadhiya; Babu, Tara M; Robinson, Samuel T; Gilbert, Peter B; Follmann, Dean; Janes, Holly; Kublin, James G; Baden, Lindsey R; Goepfert, Paul; Gray, Glenda E; Grinsztejn, Beatriz; Kotloff, Karen L; Gay, Cynthia L; Leav, Brett; Miller, Jacqueline; Hirsch, Ian; Sadoff, Jerald; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Falsey, Ann R; El Sahly, Hana M; Sobieszczyk, Magdalena E; Huang, Yunda

No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial

一项随机试验表明,在50岁及以上成年人中,同时接种佐剂重组带状疱疹疫苗和2019冠状病毒病mRNA-1273加强疫苗不会产生免疫干扰或安全问题。

Naficy, Abdi; Kuxhausen, Adrienne; Pirrotta, Paola; Leav, Brett; Miller, Jacqueline; Anteyi, Kate; Danier, Jasur; Breuer, Thomas; Mwakingwe-Omari, Agnes